Prasinezumab in Parkinson’s disease: delayed-start analysis of PASADENA trial Presented ByDr Gennaro Pagano, King’s College London, UK TrialPhase 2, PASADENA ConferenceAAN 2022 2 June, 2022 17:18
Effect of prasinezumab on motor features in early PD TrialPhase 2, PASADENA ConferenceEAN 2021 18 August, 2021 11:36